This briefing provides information about how environmental factors contribute to cardiovascular disease in Europe. It also identifies how policies can help alleviate the problem. It is based on data compiled by the EEA and intends to inform discussions about the EU Cardiovascular Health Plan.

Key messages

Environmental risk factors cause nearly one in five cardiovascular deaths in the EU.

The main environmental cardiovascular risk factors include air pollution, noise, chemicals and extreme temperatures.

Lowering exposure to these preventable environmental risks is key to reducing cardiovascular disease.

The One Health approach can facilitate an effective integration of the environment in EU health policies.

Introduction 

Cardiovascular disease impacts many lives in Europe. It is the most common cause of death in the EU: over 1.7 million people died from it in 2022, making up one third of all deaths within the bloc that year (EUROSTAT, 2025; Timmis et al., 2022; WHO, 2022). In addition, more than 6 million new cases of cardiovascular diseases are diagnosed every year, costing Europe about EUR 282 billion (Luengo-Fernandez et al., 2023). 

The causes of cardiovascular disease are complex, with several factors contributing to the clinical variables that affect cardiovascular health (see Figure 1). Some cardiovascular risks, such as age, and family history, are intrinsic to the individual and cannot be changed. Other risk factors, mainly behavioural and environmental ones, are modifiable through interventions and policies. Addressing them is crucial for prevention.

Figure 1. Cardiovascular disease: focus on environmental risk factors 

Please select a resource that has a preview image available.

Environmental cardiovascular risk factors

In the EU, key environmental factors, including air pollution, extreme temperatures and chemicals, are estimated to cause at least 18% of all cardiovascular disease deaths and almost 17% of the cardiovascular burden of disease, a combined measure of death and disease (IHME, 2024; Prüss-Üstün et al., 2016; Vaduganathan et al., 2022). This burden is unequally distributed across the EU, reflecting differences in exposure to key environmental risk factors (see Figure 2). Moreover, these proportions are likely underestimates, as they do not include exposure to environmental noise and many cardiotoxic chemicals (both of which are discussed further below).

Figure 2. Cardiovascular disease deaths attributable to select environmental risks in the EU

Below is an overview of the most important environmental risk factors for cardiovascular disease in the EU and their impacts.

Air pollution

Air pollution causes around 8% of the cardiovascular deaths in the EU (IHME, 2024), and PM2.5 alone causes over 130,000 ischaemic heart disease (IHD) and stroke deaths each year (EEA, 2024a). It also leads to over 1 million years of life lost annually. Fine particulate matter (PM2.5), nitrogen dioxide (NO₂), and ozone (O₃) are the three key pollutants linked to cardiovascular disease in Europe. Long-term exposure to these pollutants contributes significantly to premature mortality and chronic cardiovascular conditions, including heart attacks, strokes and heart failure. In addition, air pollution is unequally distributed; for example, PM2.5 levels are consistently higher in the EU’s poorer regions.

Did you know?

Second-hand smoke is a form of air pollution which contains around 7,000 chemicals, many of which increase the risk of stroke and coronary heart disease, and causes around 2% of cardiovascular deaths in Europe (IHME, 2024). This impact could be added to the overall environmental burden of cardiovascular disease, as second-hand smoke is an environmental exposure. Emerging evidence suggests that second-hand aerosol from electronic cigarettes may not be safe either (Bianco et al., 2021; Patanavanich et al., 2025). Smoke-free zones help prevent cardiovascular disease and the Council encourages Member States to extend smoke-free policies to key outdoor areas.

Noise pollution from transport

Long-term exposure to transport noise — from road, rail and air traffic — in Europe is associated with cardiovascular deaths and new cases of cardiovascular disease each year. Noise triggers stress responses and disrupts sleep, contributing to systemic inflammation. Over time, these effects raise the risk of developing a range of health conditions, particularly cardiovascular diseases such as IHD, stroke and heart failure (Münzel et al., 2025b). It is estimated that around 66,000 premature deaths annually in the EU are attributable to transport noise exposure, with more than 30% due to cardiovascular causes. Additionally, approximately 50,000 new cases of cardiovascular disease are linked to transport noise, representing about 0.7% of all cardiovascular disease cases in Europe (EEA, 2025a).

Chemical exposure

Exposure to toxic chemicals in the European environment, including in workplaces, also increases the risk of developing cardiovascular disease. Heavy metals such as arsenic, copper, cadmium, mercury and especially lead are linked to cardiovascular disease, even at very low exposure levels, if extended over a longer time (Shrivastav et al., 2024). Diseases include IHD, stroke and atrial fibrillation – an alteration of the heart rhythm that increases the risk of serious cardiovascular illness. Lead alone accounts for an estimated 2% to 4% of cardiovascular deaths in the EU (IHME, 2024). In various European countries, the level of lead already found in people’s blood can increase cardiovascular risk (Plass et al., 2024). Benzene and polycyclic aromatic hydrocarbons (PAHs), common air pollutants, are also associated with increased risks of heart attack and hypertension. This is particularly the case in workplaces with high exposure levels.  

Increasingly, evidence links exposure to endocrine-disrupting chemicals to harm to the cardiovascular system (Assenza et al., 2025). One phthalate alone (DEHP), a known endocrine disruptor, was estimated to result in over 27,000 cardiovascular deaths in Europe among people between 55 and 64 years old (Hyman et al., 2025). Emerging evidence is linking "forever chemicals" like per- and polyfluoroalkyl substances (PFAS), some of which are increasingly accumulating in the environment and in humans, with cardiovascular risks (Arredondo Eve et al., 2024; Zhu et al., 2024). Some of those pollutants are the target of controls under the updated water framework directive. However, we do not have a complete picture of how toxic chemicals affect cardiovascular disease. Epidemiological studies cover only a tiny fraction of the chemicals in our surroundings. Standardised test methods used to document chemical safety are often inadequate when it comes to detecting cardiovascular disease (Schaffert et al., 2023). This means we are likely to significantly underestimate how exposure to chemicals affects the cardiovascular system.

Climatic factors

Europe is facing unprecedented and escalating extreme climatic events, which can cause or exacerbate cardiovascular disease. For example, cardiovascular patients are especially vulnerable to heat, with a 16% increase in the risk of hospital admissions during heatwave days (Alho et al., 2024). An estimated 95% of the fatalities associated with weather and climate-related extremes recorded in Europe between 1980 and 2023 were linked to heatwaves (EEA, 2024b). And with 19% of the EU population reports being unable to keep their home comfortably cool during the summer (EEA, 2025b), vulnerable populations are particularly exposed to hazardously high temperatures. Moreover, heat and air pollution have a synergistic effect on health (EEA, 2023b). Climate change is set to enhance the formation of ground-level ozone and affect particulate matter concentrations via thermal inversions which trap pollution at the ground level (Doherty et al., 2017; Hamer et al., 2024). Since the beginning of 2025, 1,868 fires have been detected, burning more than 1 million hectares and making 2025 the worst year of wildfires on record in Europe. Wildfire smoke increases the risk of heart attack and stroke, especially in the elderly and those with pre-existing conditions (Hadley et al., 2022). Smoke and physically-strenuous tasks related to wildfire control also raise cardiovascular risks for firefighters (EU-OSHA, 2023; Groot et al., 2019). Heart attack is the second cause of death linked to floods after drowning (Petrucci et al., 2019).

Cold also remains a substantial risk to cardiovascular health. Low temperatures narrow our blood vessels, increasing blood pressure and forcing the heart to work harder. This can also make blood more viscous, elevating the risk of clots, stroke or heart attack. These risks are more relevant for those with a pre-existing cardiovascular condition (Manou-Stathopoulou et al., 2015). Almost 7% of cardiovascular deaths are attributable to low temperatures, an effect far stronger than that of heat (García-León et al., 2024) and worsened by energy poverty. In 2023, around 9.3% of the EU population (and 16.2% of low-income households) reported that they could not keep their homes warm enough (State of the Energy Union Report 2024 - European Commission, forthcoming).

Box 1. What has been done about environmental cardiovascular risks? Has it worked?

In 2021, the zero pollution action plan (ZPAP) set out a 2050 vision and several 2030 targets to reduce pollution. The ones on air and noise are particularly relevant for cardiovascular diseases. It also sets out nine flagships (on inequalities, urban action and regional action, among others) and 33 actions  most of which have been implemented in the meantime. The zero pollution monitoring and outlook assessment (EEA, 2025c) regularly outlines progress on preventing and reducing pollution, and evaluates environmental impacts on health.  

EU policies and regulations which aim to tackle air pollution are working. It has decreased across the EU, resulting in fewer attributable premature deaths. The EU is also on track to meet the ZPAP objective of reducing by more than 55% the premature deaths attributable to air pollution by 2030, compared to 2005. However, 95% of EU residents, particularly those in urban areas, are still exposed to unsafe pollution levels (based on the World Health Organization’s guidelines). 

Exposure to harmful environmental noise levels has not significantly decreased since 2012. The EU target of achieving a 30% reduction in those chronically disturbed by transport noise by 2030 compared to 2017 is unlikely to be met without further measures. 

Current efforts to minimise health impacts, including cardiovascular ones, from exposures aggravated by climate change are insufficient. Cardiovascular impacts are increasingly recognised in national adaptation policies (20 out of 37) and national health strategies (20 out of 34) (ECHO, 2025). However, without urgent and broad action — beyond just health sector policies — some health impacts could significantly worsen in the medium and long term. 

There has been progress in reducing the use and risk of chemical pesticides, as well as more hazardous pesticides. Thanks to human biomonitoring data from the EU-funded HBM4EU (Science and policy for a healthy future) and PARC (Partnership for the Assessment of Risks from Chemicals) studies, it has been observed that cardiotoxic chemical concentrations (for substances like lead) have decreased in EU residents’ blood — but in some cases, not yet to safe levels (Sy et al., 2024; Plass et al., 2024) .

Potential solutions

Environmental cardiovascular risk factors can be further reduced through policies and interventions that benefit large population groups at once. This would require specific action to tackle environmental risk factors, as well as broader action across sectors.

Reducing environmental cardiovascular risk factors:

  • Air pollution: effectively implementing the revised Ambient Air Quality Directive (EU) 2024/2881 is crucial for cardiovascular protection. Specifically, the Directive will help reduce air pollution levels, bring them closer to the WHO recommendations and help achieve the ZPAP objectives. The Directive’s requirement to provide health-related information tailored to sensitive populations, including those with pre-existing health conditions, is expected to help protect cardiovascular patients.
  • Environmental noise: reducing transport noise to achieve the ZPAP objectives requires large-scale interventions, stronger regulatory action, improved urban planning and greater awareness of its health impacts. Many urban planning measures that reduce noise, such as increasing access to calm, green areas and promoting active modes of transport, are de-stressing and encourage movement. These, too, can benefit cardiovascular health.
  • Chemicals: reducing cardiovascular risks from chemicals depends on better enforcing chemical regulations, accelerating the phase-out of cardiotoxic substances and promoting safer alternatives to them. Monitoring and human biomonitoring should be improved, especially for emerging contaminants. It is also crucial to support research activities to increase the knowledge base, including by developing new approach methods (NAMs) to test chemicals for cardiovascular effects.
  • Climate change: health systems should prepare for and mitigate climatic impacts on cardiovascular health through early warning systems, public health campaigns and targeted support for vulnerable groups (e.g. within heat-health action plans). Better integrating health into climate adaptation planning, especially at the local government level, is essential as climate risks grow. Action in this area can be supported by evidence, including case studies and indicators, available at the European Climate and Health Observatory.  

Acting in an integrated way:

  • One Health approach: Integrating environmental considerations in actions to prevent non-communicable diseases could strengthen the EU One Health approach, which is based on the interconnection and interdependence between the health of humans, animals, plants and the wider environment. Strong and concerted action at both EU and global level is only possible through agile cross-sectoral collaboration between the health, chemicals, climate and environment sectors.
  • Public awareness and education: public health campaigns can effectively raise awareness about cardiovascular risks from environmental stressors and promote lifestyle changes (Münzel et al., 2025). Personal actions to reduce exposure (e.g. to air pollution) can complement, not replace, system-wide emission reductions. EEA tools like the European Environment and health atlas, the Air quality index and the European city air quality viewer, as well as the zero pollution dashboards for regions and cities, can be used by patients and health practitioners.
  • Health workforce awareness and engagement: while some medical schools are expanding curricula to include environmental health and climate change, most still lack formal education on these topics. As of 2020, about 75% of European medical schools did not cover climate change and health, and in 2022, most doctors and nurses in France, Germany and the UK lacked environmental literacy support (EEA, 2024c). At the same time, the success of initiatives such as the Nurses Climate Challenge Europe or the European Climate and Health Responder Course demonstrates that healthcare and public health professionals have an appetite for learning more about the intersections between health and the environment.
  • Nature-based solutions: urban greening, parks, green corridors and blue spaces reduce cardiovascular risk by improving air quality, reducing noise pollution, reducing exposure to heat, encouraging physical activity and alleviating stress (WHO, 2025). Examples of nature-based solutions that protect health can be found at the European Climate and Health Observatory repositories. 

Identifiers for EEA Briefing 12/2025:
Title: Preventing cardiovascular disease through a healthy environment
HTML: TH-01-25-032-EN-Q - ISBN: 978-92-9480-738-0 - ISSN: 2467-3196 - doi: 10.2800/5535347

Alho, A. M., et al., 2024, ‘Effect of heatwaves on daily hospital admissions in Portugal, 2000–18: an observational study’, The Lancet Planetary Health 8(5), pp. e318-e326 (DOI: 10.1016/S2542-5196(24)00046-9). 

Arredondo Eve, A., et al., 2024, ‘PFAS and their association with the increased risk of cardiovascular disease in postmenopausal women’, Toxicological Sciences 200(2), pp. 312-323 (DOI: 10.1093/toxsci/kfae065). 

Assenza, M. R., et al., 2025, ‘The effect of endocrine disruptors on the cardiovascular system: does sex matter?’, Environmental Research 277, p. 121612 (DOI: 10.1016/j.envres.2025.121612). 

Bianco, E., et al., 2021, ‘E-Cigarettes: A New Threat to Cardiovascular Health – A World Heart Federation Policy Brief | Global Heart’, (DOI: 10.5334/gh.1076). 

Doherty, R. M., et al., 2017, ‘Climate change impacts on human health over Europe through its effect on air quality’, Environmental Health 16(1), p. 118 (DOI: 10.1186/s12940-017-0325-2). 

ECHO, 2025, National policy analysis. Climate-ADAPT., European Climate and Health Observatory (https://climate-adapt.eea.europa.eu/en/observatory/policy-context/national-policy-analysis) accessed 23 September 2025. 

EEA, 2023a, Beating cardiovascular disease — the role of Europe’s environment, EEA Web Report (https://www.eea.europa.eu/publications/beating-cardiovascular-disease) accessed 15 June 2025. 

EEA, 2023b, Combined effects of air pollution and heat exposure in Europe: Time for action., European Environment Agency, Copenhagen, Denmark (https://www.eea.europa.eu/en/newsroom/editorial/combined-effects-of-air-pollution-and-heat-exposure) accessed 7 October 2025. 

EEA, 2024a, Harm to human health from air pollution in Europe: burden of disease status, 2024, EEA Briefing (https://www.eea.europa.eu/en/analysis/publications/harm-to-human-health-from-air-pollution-2024) accessed 22 January 2025. 

EEA, 2024b, The impacts of heat on health: surveillance and preparedness in Europe, European Environment Agency, Copenhagen  Denmark (https://www.eea.europa.eu/en/analysis/publications/the-impacts-of-heat-on-health) accessed 22 January 2025. 

EEA, 2024c, Training and education resources on climate change and health. Climate-ADAPT. (https://climate-adapt.eea.europa.eu/en/observatory/publications-and-outreach/capacity-building/training-and-education-resources-1) accessed 23 September 2025. 

EEA, 2025a, Environmental noise in Europe report, No 06/2025, European Environment Agency (https://www.eea.europa.eu/en/analysis/publications/environmental-noise-in-europe-2025) accessed 8 August 2025. 

EEA, 2025b, Social fairness in preparing for climate change: how resilience can benefit communities across Europe (https://www.eea.europa.eu/en/analysis/publications/social-fairness-in-preparing-for-climate-change-how-resilience-can-benefit-communities-across-europe) accessed 17 June 2025. 

EEA, 2025c, Zero pollution monitoring and outlook 2025, EEA-JRC Report No 13/2024 (https://www.eea.europa.eu/en/analysis/publications/zero-pollution-monitoring-and-outlook-report) accessed 28 April 2025. 

EU-OSHA, 2023, The links between exposure to work-related psychosocial risk factors and cardiovascular disease, European Agency for Safety and Health at Work, Bilbao, Spain (https://osha.europa.eu/en/publications/links-between-exposure-work-related-psychosocial-risk-factors-and-cardiovascular-disease) accessed 20 October 2025. 

EUROSTAT, 2025, Eurostat, 2025. Causes of death statistics. [online], Eurostat Statistics Explained (https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Causes_of_death_statistics) accessed 19 September 2025. 

García-León, D., et al., 2024, ‘Temperature-related mortality burden and projected change in 1368 European regions: a modelling study’, The Lancet Public Health 9(9), pp. e644-e653 (DOI: 10.1016/S2468-2667(24)00179-8). 

Groot, E., et al., 2019, ‘A systematic review of the health impacts of occupational exposure to wildland fires’, International journal of occupational medicine and environmental health 32(2), pp. 121-140 (DOI: 10.13075/ijomeh.1896.01326). 

Hadley, M. B., et al., 2022, ‘Protecting Cardiovascular Health From Wildfire Smoke’, Circulation 146(10), pp. 788-801 (DOI: 10.1161/CIRCULATIONAHA.121.058058). 

Hamer, P. D., et al., 2024, ‘Copernicus Atmosphere Monitoring Service Interim Annual Assessment Report on European Air Quality in 2023’, (DOI: 10.24380/LLGC-6T3R). 

Hyman, S., et al., 2025, ‘Phthalate exposure from plastics and cardiovascular disease: global estimates of attributable mortality and years life lost’, eBioMedicine 117 (DOI: 10.1016/j.ebiom.2025.105730). 

IHME, 2024, Global Burden of Disease Study 2021 (GBD 2021)., Seattle, United States: Institute for Health Metrics and Evaluation (IHME), (https://www.healthdata.org/). 

Luengo-Fernandez, R., et al., 2023, ‘Economic burden of cardiovascular diseases in the European Union: a population-based cost study’, European Heart Journal 44(45), pp. 4752-4767 (DOI: 10.1093/eurheartj/ehad583). 

Manou-Stathopoulou, V., et al., 2015, ‘The effects of cold and exercise on the cardiovascular system’, Heart 101(10), pp. 808-820 (DOI: 10.1136/heartjnl-2014-306276). 

Münzel, T., et al., 2025, ‘A comprehensive review/expert statement on environmental risk factors of cardiovascular disease’, Cardiovascular Research, p. cvaf119 (DOI: 10.1093/cvr/cvaf119). 

Patanavanich, R., et al., 2025, ‘Health Effects from Secondhand Exposure to E-Cigarettes: A Systematic Review of Peer-Reviewed Articles from 2004–2024’, International Journal of Environmental Research and Public Health 22(9), p. 1408 (DOI: 10.3390/ijerph22091408). 

Petrucci, O., et al., 2019, ‘Flood Fatalities in Europe, 1980–2018: Variability, Features, and Lessons to Learn’, Water 11(8), p. 1682 (DOI: 10.3390/w11081682). 

Plass et al., 2024, Estimating the burden of disease due to lead, PFAS, phthalates, cadmium, pyrethroids and bisphenol A using HBM4EU data – test of feasibility and first results for selected countries., No Eionet Report – ETC HE 2023/13, European Topic Centre on Human Health and the Environment. 

Prüss-Üstün, A., et al., 2016, Preventing disease through healthy environments: a global assessment of the burden of disease from environmental risks, World Health Organization, Geneva, Switzerland. 

Schaffert, A., et al., 2023, ‘Cardiotoxicity of chemicals: Current regulatory guidelines, knowledge gaps, and needs’, ALTEX 40(2), pp. 337-340 (DOI: 10.14573/altex.2301121). 

Shrivastav, A., et al., 2024, ‘The Impact of Environmental Toxins on Cardiovascular Diseases’, Current Problems in Cardiology 49(1, Part C), p. 102120 (DOI: 10.1016/j.cpcardiol.2023.102120). 

Sy, M., et al., 2024, ‘Assessment of the Long-Term Exposure to Lead in Four European Countries Using PBPK Modeling’, Exposure and Health 16(1), pp. 21-39 (DOI: 10.1007/s12403-023-00535-2). 

Timmis, A., et al., 2022, ‘European Society of Cardiology: cardiovascular disease statistics 2021’, European Heart Journal 43(8), pp. 716-799 (DOI: 10.1093/eurheartj/ehab892). 

Vaduganathan, M., et al., 2022, ‘The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health’, Journal of the American College of Cardiology 80(25) (DOI: 10.1016/j.jacc.2022.11.005). 

WHO, 2022, Global Health Observatory, World Health Organization, Geneva, Switzerland (https://www.who.int/data/gho) accessed 20 October 2025. 

WHO, 2025, Nature-based solutions and health, No WHO/EURO:2025-12214-51986-79744, Copenhagen, Denmark (https://www.who.int/europe/publications/i/item/WHO-EURO-2025-12214-51986-79744) accessed 20 October 2025. 

Zhu, L., et al., 2024, ‘Per- and polyfluoroalkyl substances, apolipoproteins and the risk of coronary heart disease in US men and women’, Environmental Health 23(1), p. 108 (DOI: 10.1186/s12940-024-01147-2). 

State of the Energy Union Report 2024 - European Commission (https://energy.ec.europa.eu/publications/state-energy-union-report-2024_en) accessed 19 September 2025.

The European Environment Agency (EEA) would like to thank the European Commission Directorate Generals for Environment, Climate Action, and Health and Consumer Safety, as well as the Environment task force of the European Society of Cardiology, for their valuable contributions and input.